Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Y Wen

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Histopathology|January 7, 2026
Mucin-producing breast lesions: a practical approach to diagnosisSunayana Misra, Mihir Gudi, Kimberly H Allison, et al.
Breast Cancer Research and Treatment|July 14, 2017
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancerGulisa Turashvili, Joanne F Chou, Edi Brogi, et al.
Breast Cancer Research and Treatment|October 21, 2022
Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of ageAustin D Williams, Kate R Pawloski, Hannah Y Wen, et al.
Histopathology|July 8, 2024
Best practices for achieving consensus in HER2-low expression in breast cancer: current perspectives from practising pathologistsGary Tozbikian, Marilyn M Bui, David G Hicks, et al.
NPJ Breast Cancer|July 23, 2021
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinomaWillard Wong, Edi Brogi, Jorge S Reis-Filho, et al.
Breast Cancer Research and Treatment|August 29, 2020
Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasiaKate R Pawloski, Nicole Christian, Andrea Knezevic, et al.
Histopathology|April 29, 2025
Clinicopathological features of microinvasive lobular carcinomaRachel Han, Atif A Hashmi, Hannah Y Wen, et al.
Breast Cancer Research and Treatment|September 28, 2023
Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scoresAnne Grabenstetter, Edi Brogi, Donna M Thompson, et al.
Breast Cancer Research and Treatment|November 9, 2021
Supervised machine learning model to predict oncotype DX risk category in patients over age 50Kate R Pawloski, Mithat Gonen, Hannah Y Wen, et al.
NPJ Breast Cancer|August 11, 2022
Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapyAnne Grabenstetter, Edi Brogi, Hong Zhang, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Histopathology|January 7, 2026
Mucin-producing breast lesions: a practical approach to diagnosisSunayana Misra, Mihir Gudi, Kimberly H Allison, et al.
Breast Cancer Research and Treatment|July 14, 2017
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancerGulisa Turashvili, Joanne F Chou, Edi Brogi, et al.
Breast Cancer Research and Treatment|October 21, 2022
Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of ageAustin D Williams, Kate R Pawloski, Hannah Y Wen, et al.
Histopathology|July 8, 2024
Best practices for achieving consensus in HER2-low expression in breast cancer: current perspectives from practising pathologistsGary Tozbikian, Marilyn M Bui, David G Hicks, et al.
NPJ Breast Cancer|July 23, 2021
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinomaWillard Wong, Edi Brogi, Jorge S Reis-Filho, et al.
Breast Cancer Research and Treatment|August 29, 2020
Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasiaKate R Pawloski, Nicole Christian, Andrea Knezevic, et al.
Histopathology|April 29, 2025
Clinicopathological features of microinvasive lobular carcinomaRachel Han, Atif A Hashmi, Hannah Y Wen, et al.
Breast Cancer Research and Treatment|September 28, 2023
Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scoresAnne Grabenstetter, Edi Brogi, Donna M Thompson, et al.
Breast Cancer Research and Treatment|November 9, 2021
Supervised machine learning model to predict oncotype DX risk category in patients over age 50Kate R Pawloski, Mithat Gonen, Hannah Y Wen, et al.
NPJ Breast Cancer|August 11, 2022
Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapyAnne Grabenstetter, Edi Brogi, Hong Zhang, et al.
Pageof 11